InCarda Therapeutics Funding & Investors
Newark, CA
InCarda Therapeutics, Inc. operates as a biotechnology company. The Company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics focuses on the development and commercialization of therapies for acute cardiovascular conditions.
incardatherapeutics.comTotal Amount Raised: $129,376,976
InCarda Therapeutics Funding Rounds
Series A
$43,000,000
Series A Investors
Andreessen HorowitzBiovision VenturesValhalla VenturesIndicator VenturesRV InvestGVGaingelsEli Lilly and Company FoundationAlumni VenturesMana VenturesLifeLink VenturesTwo Sigma VenturesExitfundSeries Unknown
$8,500,000
Series C
$30,000,000
Series C Investors
InnovivaDeerfield ManagementHealthCapThe Morningside GroupSeries B
$42,000,000
Series B Investors
HealthCapSofinnova PartnersMorningside VenturesDeerfield ManagementAsset Management VenturesSeries A
$5,000,000
Series A Investors
Morningside Private InvestorsSeed
$566,977
Debt Financing
$310,000
Funding info provided by Diffbot.